↓ Skip to main content

Chemotherapy-Induced Peripheral Neuropathy Assessment Tools: A Systematic Review

Overview of attention for article published in Oncology Nursing Forum, May 2017
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
1 X user
f1000
1 research highlight platform

Citations

dimensions_citation
41 Dimensions

Readers on

mendeley
104 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Chemotherapy-Induced Peripheral Neuropathy Assessment Tools: A Systematic Review
Published in
Oncology Nursing Forum, May 2017
DOI 10.1188/17.onf.e111-e123
Pubmed ID
Authors

Haryani Haryani, Susan Jane Fetzer, Ching-Lin Wu, Yu-Yun Hsu

Abstract

Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting chemotherapy toxicity, which has a long-lasting effect and decreases quality of life. Although several tools have been developed to detect CIPN, the study quality, psychometric properties, and practicality of CIPN assessment tools have not been systematically reviewed.
. Electronic searches using keywords were conducted in Medline, PubMed, CINAHL®, and Cochrane Library for articles published from 1980-2015. Eligible studies were included if they involved patients with cancer receiving chemotherapy, provided CIPN assessment tools with psychometric properties, and were published in English.
. Data were extracted, and study quality was assessed. CIPN tools were evaluated in terms of psychometric properties and practicality.
. A total of 19 studies describing 20 tools were reviewed. The quality of studies varied from strong to weak. The validity ranged from low to high, and the reliability with internal consistency ranged from 0.56-0.96. Poor inter-rater agreement was found. Not all of the tools were deemed practical.
. Considering the psychometric properties and practicality, two tools (Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity [FACT/GOG-Ntx] and Total Neuropathy Score [TNS]) are recommended for assessing CIPN.
. Routine assessment of CIPN and choosing appropriate assessment tools are imperative. The FACT/GOG-Ntx and TNS are recommended for clinical use.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 104 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 104 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 16 15%
Student > Bachelor 11 11%
Researcher 9 9%
Student > Ph. D. Student 8 8%
Other 7 7%
Other 23 22%
Unknown 30 29%
Readers by discipline Count As %
Nursing and Health Professions 25 24%
Medicine and Dentistry 24 23%
Neuroscience 5 5%
Engineering 3 3%
Psychology 3 3%
Other 11 11%
Unknown 33 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 February 2020.
All research outputs
#14,349,470
of 22,977,819 outputs
Outputs from Oncology Nursing Forum
#355
of 641 outputs
Outputs of similar age
#173,503
of 310,777 outputs
Outputs of similar age from Oncology Nursing Forum
#5
of 7 outputs
Altmetric has tracked 22,977,819 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 641 research outputs from this source. They receive a mean Attention Score of 4.4. This one is in the 40th percentile – i.e., 40% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 310,777 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.